✦ LIBER ✦

9212 Rituximab does not seem to influence the risk of central nervous system occurrence in patients with diffuse large B cell lymphoma

✍ Scribed by Chung, S.; Tai, W.M.; Ravi, K.; Tan, I.B.; Tan, M.Y.; Ngeow, J.; Koo, Y.X.; Tao, M.; Quek, R.; Lim, S.T.

Book ID: 122012145
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 70 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71903-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Central nervous system event in patients

Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era

✍ Naoto Tomita; Masahiro Yokoyama; Wataru Yamamoto; Reina Watanabe; Yutaka Shimazu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

The addition of rituximab reduces the in

The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma

✍ Zdravko Mitrovic; Martin Bast; Philip J. Bierman; Robert G. Bociek; Julie M. Vos 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Secondary central nervous system involve

Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?

✍ Deng, Lijuan; Song, Yuqin; Zhu, Jun; Zheng, Wen; Wang, Xiaopei; Xie, Yan; Lin, N 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 250 KB

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Kacey O'Rourke; Kirk Morris; Glen A. Kennedy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Matthew Hellmann; Jeffrey A. Barnes; Peter Hammerman; Christ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Reply to intravenous methotrexate as cen

Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Ephraim P. Hochberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

I read with great interest the article by Cooperberg and coworkers 1 studying survival rates in differently treated men with early prostate cancer. In this study, patients who underwent radical prostatectomy had a substantially decreased disease-specific mortality, particularly in the higher-risk gr